Puff Bar's Switch to Synthetic Nicotine: FDA Regulations, Delays, and WeAreDragon's Commitment

In 2021, Puff Bar transitioned to using laboratory-made nicotine, triggering Congressional action to close a regulatory loophole. However, this shift resulted in a backlog of FDA applications for synthetic nicotine products, with the FDA legally obligated to make timely decisions.

This situation raised questions about the FDA's regulatory efficiency and adherence to statutory timelines. It also underlines the complexities of synthetic nicotine product approvals.

In response to these challenges, WeAreDragon has demonstrated its commitment to responsible business practices by ensuring compliance with FDA regulations and public health standards. WeAreDragon has taken a proactive approach to support the FDA's regulatory efforts and made a decision to cease all sales of Puff Bars.